Smith, J, Fritz, E L, Kerr, J R et al. · Journal of clinical pathology · 2005 · DOI
This study looked at whether certain genetic markers related to the immune system (called HLA types) are more common in people with ME/CFS than in healthy people. Researchers compared the genetic profiles of 49 ME/CFS patients with 102 healthy controls from the same region of England. They found that one particular genetic marker (HLA-DQA1*01) was significantly more common in ME/CFS patients, suggesting genes may play a role in who develops this illness.
Understanding genetic factors in ME/CFS could help explain why only some people develop the illness and others do not, potentially leading to earlier identification of at-risk individuals. If HLA associations are confirmed, it may point toward immune-related mechanisms underlying ME/CFS pathogenesis and could guide future treatment development.
This study does not prove that HLA-DQA1*01 causes ME/CFS—only that it is more frequently present in affected individuals. The association could reflect linkage with other nearby genes rather than HLA itself being causative. Additionally, the modest sample size and single-region recruitment limit generalizability, and replication in larger, diverse populations is needed.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →